What is NDC 80005-139?

80005-139 is the product NDC for Letrozole, Letrozole 2.5 mg/1 tablet, film coated, listed with the FDA by Carnegie Pharmaceuticals LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.

Carnegie Pharmaceuticals LLC, NDC labeler code 80005. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Letrozole?

22 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Letrozole NDC 80005-139 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)80005-139Labeler and product segments. Claims need a package NDC.

Product NDC at billing width80005-0139Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
80005-139-08	8000501390880005013908	30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (80005-139-08)Marketed from Jun 30, 2026
80005-139-10	8000501391080005013910	90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (80005-139-10)Marketed from Jun 30, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Letrozole
Generic name (nonproprietary): letrozole
Active ingredients: Letrozole — 2.5 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Carnegie Pharmaceuticals LLCNDC labeler code 80005
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 091191
Marketing start: Jun 30, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Aromatase Inhibitors (Mechanism)
Identifiers: Product ID 80005-139_9fb66539-2efe-47cc-9b78-85b096caac95SPL ID 9fb66539-2efe-47cc-9b78-85b096caac95SPL set ID cb1da0ac-8db1-4482-824d-430511d1b7a0RxCUI 200064UNII 7LKK855W8I
Pharmacologic class: Aromatase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N480005013908 followed by a unit qualifier and the quantity

Package 80005-0139-08. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 29, 2026.

Indications (excerpt from the label)

Letrozole is an aromatase inhibitor indicated for: Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer. ( 1.1 ) Extended adjuvant treatment of postmenopausal women with early breast cancer who have received prior standard adjuvant tamoxifen therapy. ( 1.2 ) First and second-line treatment of postmenopausal women with hormone receptor positive or unknown advanced breast cancer. ( 1.3 ) 1.1 Adjuvant Treatment of Early Breast Cancer Letrozole tablets are indicated for the adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer. 1.2 Extended Adjuvant Treatment of Early Breast Cancer Letrozole tablets are indicated fo…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 80005-139

What is NDC 80005-139?: 80005-139 is the product NDC for Letrozole, Letrozole 2.5 mg/1 tablet, film coated, listed with the FDA by Carnegie Pharmaceuticals LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Letrozole.
What is the active ingredient?: Letrozole.
Who is the labeler?: Carnegie Pharmaceuticals LLC, NDC labeler code 80005. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Letrozole?: 22 other product NDCs are listed under this name. See all Letrozole NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Letrozole NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Letrozoleletrozole tablets	Letrozole 2.5 mg/1	Tablet, Film coatedOral	Upsher-Smith Laboratories, LLC	24979-726	24979-0726-07
Letrozoleletrozole tablets	Letrozole 2.5 mg/1	Tablet, Film coatedOral	Avet Pharmaceuticals Inc.	23155-875	23155-0875-0323155-0875-0923155-0875-10
Letrozoleletrozole tablets	Letrozole 2.5 mg/1	Tablet, Film coatedOral	Bryant Ranch Prepack	71335-2396	71335-2396-0171335-2396-0271335-2396-03+1 more
Letrozole	Letrozole 2.5 mg/1	Tablet, Film coatedOral	ATLANTIC BIOLOGICALS CORP.	17856-0032	17856-0032-01
Letrozole	Letrozole 2.5 mg/1	TabletOral	AvPAK	50268-476	50268-0476-15
Letrozoleletrozole tablets	Letrozole 2.5 mg/1	Tablet, Film coatedOral	Yiling Pharmaceutical, Inc.	69117-0004	69117-0004-01
Letrozole	Letrozole 2.5 mg/1	Tablet, Film coatedOral	Chartwell RX, LLC	62135-491	62135-0491-3062135-0491-90
Letrozole	Letrozole 2.5 mg/1	Tablet, Film coatedOral	Aurobindo Pharma Limited	59651-180	59651-0180-3059651-0180-90
Letrozoleletrozole tablets	Letrozole 2.5 mg/1	Tablet, Film coatedOral	Golden State Medical Supply, Inc.	51407-986	51407-0986-90
Letrozole	Letrozole 2.5 mg/1	Tablet, Film coatedOral	AvKARE	42291-374	42291-0374-3042291-0374-90

All 23 Letrozole NDCs

Other NDCs under ANDA 091191

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 091191
Product	Strength	Form · route	Labeler	Product NDC
Letrozole	Letrozole 2.5 mg/1	Tablet, Film coatedOral	Dr. Reddy's Laboratories Limited	55111-646